Skip to main content
Have a personal or library account? Click to login
Genetically Triggered Thoracic Aortic Disease: Who Should be Tested? Cover

Genetically Triggered Thoracic Aortic Disease: Who Should be Tested?

Methodist DeBakey Cardiovascular Journal
Volume 19 (2023): Issue 2
By: ,   and    
Open Access
|Mar 2023
Figures & tables

Figures & Tables

Table 1

Pathogenic variants associated with heritable thoracic aortic disease (HTAD).

TYPE OF HTADGENETIC ABNORMALITY
Syndromic HTAD
    Marfan SyndromeFBN1
    Loeys-Dietz SyndromeTGFBR1 TGFBR2 SMAD2
SMAD3
TGFB2,
TGFB3
    Vascular Ehlers-Danlos Syndrome (type IV)COL3A1
Nonsyndromic HTADACTA2, MYH11, MYLK, LOX, and PRKG1
DOI: https://doi.org/10.14797/mdcvj.1218 | Journal eISSN: 1947-6108
Journal RSS Feed
Language: English
Page range: 24 - 28
Submitted on: Feb 10, 2023
Accepted on: Feb 15, 2023
Published on: Mar 7, 2023
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
heritable thoracic aortic diseases (HTAD),
thoracic aortic aneurysms (TAD),
Marfan syndrome (MFS),
genetic testing,
nonsyndromic HTAD,
genetic variants

© 2023 Valeria E. Duarte, Raman Yousefzai, Michael N. Singh, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.

Volume 19 (2023): Issue 2
Previous article
Next article